Skip to main content
Premium Trial:

Request an Annual Quote

Karen Eastham, Ronald Matricaria, William Mercer, Matthew Kalnik, Krishnan Nandabalan

Premium

Karen Eastham has been appointed to the board of directors of Illumina, the company announced last week. She is executive vice president, COO, and a member of the board of trustees of the Burnham Institute. Prior to that, she was senior vice president and CFO of Diversa. Eastham holds an MBA and a BS from Indiana University. She also serves on the boards of directors of Tercica, Oncosis/Cyntellect, and Salmedix, as well on the board of UCSD Athena.


Ronald Matricaria has joined the board of directors of Invitrogen, replacing William Mercer, who is retiring. Matricaria is the former chairman and CEO of St. Jude Medical. Before his term at St. Jude, he spent 23 years at Eli Lilly, where his last position was executive vice president of the pharmaceutical division and president of its North American operations. He also had held the position of CEO at Lilly subsidiary Cardiac Pacemakers. Matricaria also serves on the boards of directors of Cyberonics, VistaCare, and CardioDynamics, and is chairman of the board of Haemonetics.


Matthew Kalnik has been named senior vice president of business development of Genaissance Pharmaceuticals, where he will be responsible for the commercial-ization of the firm’s pharmacogenomic, diagnostic, and therapeutic products. Kalnik most recently held the position of executive director, head of pharmacogenomics, commercial development operations in the global prescription business at Pharmacia and then Pfizer, following its acquisition of Pharmacia. The firm also announced that Krishnan Nandabalan has been promoted to the position of vice president of corporate development, primarily responsible for expanding the firm’s HAP Technology into new markets and disease areas.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.